

US Food and Drug Administration (USFDA) has classified the Alembic Pharmaceuticals General Oral Solid Formulation Facility located at Panelav as Voluntary Action Indicated (VAI).

US Food and Drug Administration (USFDA) has classified the Alembic Pharmaceuticals General Oral Solid Formulation Facility located at Panelav as Voluntary Action Indicated (VAI).

AbbVie a research-based global biopharmaceutical company, and Allergan plc, a leading global pharmaceutical company, announced that the U.S. Federal Trade Commission (FTC) has accepted the proposed consent order in connection with AbbVie's pending acquisition of Allergan.
The state's premier educational institution ISF College of Pharmacy, Dr. G. D. Gupta, Director invented “Wearable Infection Protection Ring”. Dr. Gupta told during a special conversation that wearing this ring will help in avoiding Covid-19 pandemic disease.
Scientists from Jawaharlal Nehru Centre For Advanced Scientific Research (JNCASR) an autonomous institute under the Department of Science & Technology (DST), Govt. of India have modified the structure of Berberine, a natural and cheap product similar to curcumin, available commercially, into Ber-D to use as a Alzheimer’s inhibitor. Their research work has been published in the scientific journal iSceince. Alzheimer’s disease is the most prevalent neurodegenerative disorder and accounts for more than 70% of all dementia. The multifactorial nature of the disease attributed to multifaceted toxicity has made it difficult for researchers to develop effective medication.
Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients, which began on February 21. The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is the first clinical trial launched in the United States to evaluate an experimental treatment for COVID-19.
CSIR-Central Scientific Instruments Organisation (CSIR-CSIO), Chandigarh, has designed and developed an innovative technology for effective disinfection and sanitization to fight with corona pandemic. CSIR-CSIO has transferred this technology to a Nagpur-based company, Rite Water Solutions Pvt. Ltd., for commercialization and large-scale production. This technology has been found very efficient and effective to stop the spread of coronavirus and pathogens, say CSIR-CSIO scientists.

Heads of state and global health leaders today made an unprecedented commitment to work together to accelerate the development and production of new vaccines, tests and treatments for COVID-19 and assure equitable access worldwide.